Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02835599 : Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now
AgesMin: N/A Max: N/A
Inclusion Criteria:

1. ?19 years of age

2. Patients with a primary diagnosis of NSCLC within the past 5 years who are eligible
for their first systemic therapy based on disease characteristics. Systemic therapy
may include any cytotoxic, targeted, immune-based, or otherwise non-local treatment
modality. Specific allowed settings include the following:

1. Incident metastatic disease (stage IV) undergoing palliative therapy

2. Non-metastatic disease undergoing adjuvant, neoadjuvant, or concurrent
chemoradiation with either curative or palliative intent

3. Recurrent or subsequently metastatic disease (any stage)

3. Pathologic confirmation of malignancy prior to initiation of first systemic therapy

4. Submission of archival biospecimen sample(s) (collected up to two years prior) for

5. Availability of key variables at the time of screening (e.g. stage, demographics)

6. Have been fully informed and are able to provide written consent for longitudinal
follow-up and agree to be accessible by phone

7. Patients may be concurrently enrolled in unblinded clinical trials, but not blinded
clinical trials in which the treatment being administered is unknown

Exclusion Criteria:

1. Pre-specified enrollment caps have been met (Figure 1)

2. Suspected recurrent or subsequently metastatic disease that is not biopsy confirmed
prior to receipt of initial systemic therapy
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557